Subtypes of Nonmedical Prescription Drug Misuse
Overview
Affiliations
This study used three characteristics (i.e., motive, route of administration, and co-ingestion with alcohol) of nonmedical prescription drug misuse across four separate classes (i.e., pain, sedative/anxiety, sleeping, and stimulant medications) to examine subtypes and drug related problems. A Web survey was self-administered by a randomly selected sample of 3639 undergraduate students attending a large midwestern 4-year U.S. university. Self-treatment subtypes were characterized by motives consistent with the prescription drug's pharmaceutical main indication, oral only routes of administration, and no co-ingestion with alcohol. Recreational subtypes were characterized by recreational motives, oral or non-oral routes, and co-ingestion. Mixed subtypes consisted of other combinations of motives, routes, and co-ingestion. Among those who reported nonmedical prescription drug misuse, approximately 13% were classified into the recreational subtype, while 39% were in the self-treatment subtype, and 48% were in the mixed subtype. There were significant differences in the subtypes in terms of gender, race and prescription drug class. Approximately 50% of those in subtypes other than self-treatment screened positive for drug abuse. The odds of substance use and abuse were generally lower among self-treatment subtypes than other subtypes. The findings indicate subtypes should be considered when examining nonmedical prescription drug misuse, especially for pain medication.
Dash G, Gizer I, Martin N, Slutske W J Psychopathol Clin Sci. 2024; 133(5):378-391.
PMID: 38815084 PMC: 11869234. DOI: 10.1037/abn0000921.
Everybody's Doing It: Initiation to Prescription Drug Misuse.
Mui H, Sales P, Murphy S J Drug Issues. 2024; 44(3):236-253.
PMID: 38318234 PMC: 10843830. DOI: 10.1177/0022042613497935.
Dash G, Gizer I, Slutske W Drug Alcohol Depend. 2024; 255:111084.
PMID: 38232646 PMC: 10842745. DOI: 10.1016/j.drugalcdep.2024.111084.
Initial validation of the expectancies for Benzodiazepine Analgesia Scale.
Lape E, Powers J, LaRowe L, Ditre J Exp Clin Psychopharmacol. 2023; 32(3):369-378.
PMID: 38010761 PMC: 11098706. DOI: 10.1037/pha0000692.
Alswayed K, Alshuaibi S, Alsayegh H, Bin Shulhub A, Alsultan R, AlKhudhair M J Family Med Prim Care. 2022; 11(4):1455-1461.
PMID: 35516669 PMC: 9067198. DOI: 10.4103/jfmpc.jfmpc_1720_21.